Literature DB >> 10395177

Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines.

K Yamaguchi1, K Okami, K Hibi, S L Wehage, J Jen, D Sidransky.   

Abstract

Aneuploidy is frequently observed in many types of human cancer cells, suggesting that mutations of genes required for chromosomal stability may occur in human tumors. The BUB gene is a component of the mitotic checkpoint in budding yeast that delays anaphase in the presence of spindle damage thus increasing the probability of successful delivery of a euploid genome to each daughter cell. Recently, human homologues of the BUB gene were identified and mutant alleles of hBUB1 were detected in two colorectal tumor cell lines. Transfection of one mutant allele led to dominant disruption of the mitotic checkpoint control in a euploid cell, suggesting that aneuploidy in some tumors could be due to defects in the mitotic checkpoint. We analyzed the entire coding sequence of hBUB1 for mutation in 31 head and neck squamous cell carcinoma (HNSCC) and lung cancer cell lines, most with severe aneuploidy. We found expression of the hBUB1 gene in all cell lines and only a single nucleotide substitution in one cell line without a resultant change in amino acid sequence. Our study demonstrates that hBUB1 is rarely a target for genetic alterations in tumors of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395177     DOI: 10.1016/s0304-3835(99)00035-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Authors:  April L Blajeski; Vy A Phan; Timothy J Kottke; Scott H Kaufmann
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells.

Authors:  V M Draviam; I Shapiro; B Aldridge; P K Sorger
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

3.  Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.

Authors:  Michael J Bond; Marina Bleiler; Lauren E Harrison; Eric W Scocchera; Masako Nakanishi; Narendran G-Dayanan; Santosh Keshipeddy; Daniel W Rosenberg; Dennis L Wright; Charles Giardina
Journal:  Mol Cancer Res       Date:  2018-05-16       Impact factor: 5.852

4.  Aneuploid colon cancer cells have a robust spindle checkpoint.

Authors:  A Tighe; V L Johnson; M Albertella; S S Taylor
Journal:  EMBO Rep       Date:  2001-07-03       Impact factor: 8.807

5.  Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer.

Authors:  Chew-Wun Wu; Chin-Wen Chi; Tze-Sing Huang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.

Authors:  Zheng Fu; Kevin Regan; Lizhi Zhang; Michael H Muders; Stephen N Thibodeau; Amy French; Yanhong Wu; Scott H Kaufmann; Wilma L Lingle; Junjie Chen; Donald J Tindall
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

8.  Epigenetic inactivation of CHFR in human tumors.

Authors:  Minoru Toyota; Yasushi Sasaki; Ayumi Satoh; Kazuhiro Ogi; Takefumi Kikuchi; Hiromu Suzuki; Hiroaki Mita; Nobuyuki Tanaka; Fumio Itoh; Jean-Pierre J Issa; Kam-Wing Jair; Kornel E Schuebel; Kohzoh Imai; Takashi Tokino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

9.  Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation.

Authors:  F McKeon
Journal:  Breast Cancer Res       Date:  1999-10-07       Impact factor: 6.466

10.  Cancer karyotypes: survival of the fittest.

Authors:  Joshua M Nicholson; Daniela Cimini
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.